Description The purpose of this clinical practice update is to define key principles in the
surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

Simple Summary Hepatocellular carcinoma and cholangiocarcinoma continue to remain a
serious threat. In this review, we describe the most common biomarkers and genetic markers …

Simple Summary Most patients with a pancreatic ductal adenocarcinoma develop a
recurrence after surgery. Predictive factors may therefore guide therapeutic decision …

Background Pancreatic ductal adenocarcinoma (PDAC) detains a dismal prognosis and has
a limited number of prognostic factors. Inflammation has been demonstrated to play a key …

Simple Summary Pancreatic cancer is one of the most heterogeneous and aggressive
tumours that exist. The median survival of diagnosed patients is limited. For all these …

Pancreatic cancer (PC) continues to pose a major clinical challenge. There has been little
improvement in patient survival over the past few decades, and it is projected to become the …

BACKGROUND: Tumor markers (TMs) are a heterogeneous group of molecules used in the
diagnosis, prognosis and follow-up of cancer patients. During neoplastic differentiation, cells …

Primary sclerosing cholangitis (PSC) is a chronic, idiopathic, cholestatic liver disease
characterized by inflammation and fibrosis of the intrahepatic and/or extrahepatic bile ducts …

Background Choledochal cysts should be treated with complete surgical resection, or, rarely
liver transplantation. Treated patients can remain at risk of developing metachronous …